Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked Montmorillonite

Detalhes bibliográficos
Autor(a) principal: Shabanpour, Sakineh
Data de Publicação: 2022
Outros Autores: Pajoum Shariati, Farshid, Bagheri Khatibani, Abbas
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/205444
Resumo: In drug therapy, it is important to provide therapeutic levels of drug to the site of action and maintain them during the treatment. This work describes the in vitro release of alendronate from sodium alginate cross-linked Montmorillonite (MMT) composite beads. Effect of crosslinking cation, concentration of montmorillonite and media on encapsulation efficiencies, and release profiles of alendronate were studied. Beads were characterized using equilibrium swelling ability study, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Energy-dispersive x-ray spectroscopy (EDX) and scanning electron microscopy (SEM). Results indicate that addition of montmorillonite increases the encapsulation efficiencies and slows down the release rates significantly.
id USP-31_48bcc9c2d6fff73b3adb49fe551524cb
oai_identifier_str oai:revistas.usp.br:article/205444
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked MontmorilloniteAlendronate SodiumSodium alginateDrug deliveryMontmorilloniteIn drug therapy, it is important to provide therapeutic levels of drug to the site of action and maintain them during the treatment. This work describes the in vitro release of alendronate from sodium alginate cross-linked Montmorillonite (MMT) composite beads. Effect of crosslinking cation, concentration of montmorillonite and media on encapsulation efficiencies, and release profiles of alendronate were studied. Beads were characterized using equilibrium swelling ability study, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Energy-dispersive x-ray spectroscopy (EDX) and scanning electron microscopy (SEM). Results indicate that addition of montmorillonite increases the encapsulation efficiencies and slows down the release rates significantly.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-12-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20544410.1590/s2175-97902022e20243Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/205444/197157Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessShabanpour, SakinehPajoum Shariati, FarshidBagheri Khatibani, Abbas2023-08-11T19:47:13Zoai:revistas.usp.br:article/205444Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-08-11T19:47:13Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked Montmorillonite
title Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked Montmorillonite
spellingShingle Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked Montmorillonite
Shabanpour, Sakineh
Alendronate Sodium
Sodium alginate
Drug delivery
Montmorillonite
title_short Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked Montmorillonite
title_full Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked Montmorillonite
title_fullStr Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked Montmorillonite
title_full_unstemmed Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked Montmorillonite
title_sort Potential Alendronate Sodium drug carrier by preparation and characterization of sodium alginate cross-linked Montmorillonite
author Shabanpour, Sakineh
author_facet Shabanpour, Sakineh
Pajoum Shariati, Farshid
Bagheri Khatibani, Abbas
author_role author
author2 Pajoum Shariati, Farshid
Bagheri Khatibani, Abbas
author2_role author
author
dc.contributor.author.fl_str_mv Shabanpour, Sakineh
Pajoum Shariati, Farshid
Bagheri Khatibani, Abbas
dc.subject.por.fl_str_mv Alendronate Sodium
Sodium alginate
Drug delivery
Montmorillonite
topic Alendronate Sodium
Sodium alginate
Drug delivery
Montmorillonite
description In drug therapy, it is important to provide therapeutic levels of drug to the site of action and maintain them during the treatment. This work describes the in vitro release of alendronate from sodium alginate cross-linked Montmorillonite (MMT) composite beads. Effect of crosslinking cation, concentration of montmorillonite and media on encapsulation efficiencies, and release profiles of alendronate were studied. Beads were characterized using equilibrium swelling ability study, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Energy-dispersive x-ray spectroscopy (EDX) and scanning electron microscopy (SEM). Results indicate that addition of montmorillonite increases the encapsulation efficiencies and slows down the release rates significantly.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-23
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/205444
10.1590/s2175-97902022e20243
url https://www.revistas.usp.br/bjps/article/view/205444
identifier_str_mv 10.1590/s2175-97902022e20243
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/205444/197157
dc.rights.driver.fl_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222916612194304